Impact of DNMT3A mutations on Clinical Response to the Hypomethylating Agent Decitabine in Older Patients (pts) with Acute Myeloid Leukemia (AML)
Author:
Alison R. Walker,Klaus H. Metzeler,Susan Geyer,Heiko Becker,Sebastian Schwind,Susan P. Whitman,John Curfman,Yue-Zhong Wu,Danilo Perrotti,Rebecca B. Klisovic,Ramiro Garzon,William Blum,Guido Marcucci
Copyright © 2011 American Society of Hematology